Based on the analysis of Joint Corp's profitability, liquidity, and operating efficiency, The Joint Corp may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Joint Corp's Other Current Assets are comparatively stable compared to the past year. Total Liabilities is likely to gain to about 75.3 M in 2025, whereas Property Plant And Equipment Net is likely to drop slightly above 14.1 M in 2025. Key indicators impacting Joint Corp's financial strength include:
The financial analysis of Joint Corp is a critical element in measuring its lifeblood. Investors should not minimize Joint Corp's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Please note, the imprecision that can be found in Joint Corp's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of The Joint Corp. Check Joint Corp's Beneish M Score to see the likelihood of Joint Corp's management manipulating its earnings.
Joint Corp Stock Summary
Joint Corp competes with Encompass Health, Pennant, Enhabit, ModivCare, and Ensign. The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona. Joint Corp operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 316 people.
The reason investors look at the income statement is to determine what Joint Corp's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Joint Corp's current stock value. Our valuation model uses many indicators to compare Joint Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Joint Corp competition to find correlations between indicators driving Joint Corp's intrinsic value. More Info.
The Joint Corp is rated below average in return on equity category among its peers. It is rated fifth overall in return on asset category among its peers . At this time, Joint Corp's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Joint Corp by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Joint Corp Systematic Risk
Joint Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Joint Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Joint Corp correlated with the market. If Beta is less than 0 Joint Corp generally moves in the opposite direction as compared to the market. If Joint Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Joint Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Joint Corp is generally in the same direction as the market. If Beta > 1 Joint Corp moves generally in the same direction as, but more than the movement of the benchmark.
Joint Corp Thematic Clasifications
The Joint Corp is part of several thematic ideas from Drugs to Investing. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Joint Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Joint Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Joint Corp growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Joint Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of The Joint Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of The Joint Corp based on widely used predictive technical indicators. In general, we focus on analyzing Joint Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Joint Corp's daily price indicators and compare them against related drivers.
When running Joint Corp's price analysis, check to measure Joint Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Joint Corp is operating at the current time. Most of Joint Corp's value examination focuses on studying past and present price action to predict the probability of Joint Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Joint Corp's price. Additionally, you may evaluate how the addition of Joint Corp to your portfolios can decrease your overall portfolio volatility.